Citation Impact
Citing Papers
Alpelisib for PIK3CA -Mutated, Hormone Receptor–Positive Advanced Breast Cancer
2019 Standout
The Genetic Landscape and Clonal Evolution of Breast Cancer Resistance to Palbociclib plus Fulvestrant in the PALOMA-3 Trial
2018
PARP inhibitors: Synthetic lethality in the clinic
2017 StandoutScience
Clinical implications of the intrinsic molecular subtypes of breast cancer
2015
Overall survival results from the randomized phase 2 study of palbociclib in combination with letrozole versus letrozole alone for first-line treatment of ER+/HER2− advanced breast cancer (PALOMA-1, TRIO-18)
2020
HER2-Mutated Breast Cancer Responds to Treatment With Single-Agent Neratinib, a Second-Generation HER2/EGFR Tyrosine Kinase Inhibitor
2015
Breast cancer
2019 Standout
Triple-negative breast cancer molecular subtyping and treatment progress
2020 Standout
Cancer treatment and survivorship statistics, 2022
2022 Standout
Breast cancer statistics, 2019
2019 Standout
A view on drug resistance in cancer
2019 StandoutNature
Targeted therapies in breast cancer: are heart and vessels also being targeted?
2012
Phase II Study of Satraplatin and Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer: A Pharmacogenetic Assessment of Outcome and Toxicity
2013
ERCC1 expression as a predictive marker of squamous cell carcinoma of the head and neck treated with cisplatin-based concurrent chemoradiation
2008
ESPEN guideline: Clinical nutrition in surgery
2017 Standout
ESPEN guideline on clinical nutrition in the intensive care unit
2018 Standout
Appraising iniparib, the PARP inhibitor that never was—what must we learn?
2013
Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients
2009
A comparison of early gastric and post-pyloric feeding in critically ill patients: a meta-analysis
2006
ERCC1 Cys8092Ala and XRCC1 Arg399Gln Polymorphisms Predict Progression-Free Survival after Curative Radiotherapy for Nasopharyngeal Carcinoma
2014
ESPEN Guidelines on Enteral Nutrition: Surgery including Organ Transplantation
2006 Standout
The molecular biology of head and neck cancer
2010 Standout
Current and future perspectives of liquid biopsies in genomics-driven oncology
2018 Standout
Tumor-associated macrophages: role in cancer development and therapeutic implications
2019
An Examination of the Food Allergy Quality of Life Questionnaire Performance in a Countrywide American Sample of Children: Cross-Cultural Differences in Age and Impact in the United States and Europe
2016
Molecular mechanisms of cisplatin resistance
2011 Standout
Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient
2016 Standout
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient
2016 Standout
Pyroptosis: mechanisms and diseases
2021 Standout
Chemotherapy and the war on cancer
2005 Standout
Nasopharyngeal carcinoma
2015 Standout
A prospective cohort study of feeding needle catheter jejunostomy in an upper gastrointestinal surgical unit
2004
Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient:
2009 Standout
EAU Guidelines on Renal Cell Carcinoma: 2014 Update
2015 Standout
Food allergy: A review and update on epidemiology, pathogenesis, diagnosis, prevention, and management
2017 Standout
Clinical applications of the CellSearch platform in cancer patients
2018
Renal cell carcinoma
2017 Standout
Feeding the gut early after digestive surgery: results of a nine-year experience
2002
The history and future of targeting cyclin-dependent kinases in cancer therapy
2015 Standout
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
The side effects of platinum-based chemotherapy drugs: a review for chemists
2018 Standout
EXPERIMENTAL EVALUATION OF POTENTIAL ANTICANCER AGENTS. XIII. ON THE CRITERIA AND KINETICS ASSOCIATED WITH "CURABILITY" OF EXPERIMENTAL LEUKEMIA.
1964
Breast Cancer Statistics, 2022
2022 Standout
Genetic Polymorphisms and Head and Neck Cancer Outcomes: A Review
2008
Breast Cancer Survivorship: A Comprehensive Review of Long-Term Medical Issues and Lifestyle Recommendations
2015
Breast Cancer Treatment
2019 Standout
Early Enteral Feeding by Nasoenteric Tubes in Patients with Perforation Peritonitis
2005
Combination Chemotherapy in the Treatment of Advanced Hodgkin's Disease
1970 Standout
Delays and Disruptions in Cancer Health Care Due to COVID-19 Pandemic: Systematic Review
2021
Clinical utility of plasma Epstein‐Barr virus DNA and ERCC1 single nucleotide polymorphism in nasopharyngeal carcinoma
2015
Change in Survival in Metastatic Breast Cancer with Treatment Advances: Meta-Analysis and Systematic Review
2018
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Overall Survival with Palbociclib and Fulvestrant in Advanced Breast Cancer
2018
Excision Repair Cross Complementation Group 1 Immunohistochemical Expression Predicts Objective Response and Cancer-Specific Survival in Patients Treated by Cisplatin-Based Induction Chemotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma
2007
Works of Luís Manso being referenced
MONARCH 3: Abemaciclib As Initial Therapy for Advanced Breast Cancer
2017
Impact of the COVID-19 outbreak on cancer patient flow and management: experience from a large university hospital in Spain
2020
Quality of life in patients with food allergy
2016
Prognostic Significance of Circulating Tumor Cell Count in Patients With Metastatic Hormone-sensitive Prostate Cancer
2012
Safety and efficacy of neratinib (HKI-272) plus vinorelbine in the treatment of patients with ErbB2-positive metastatic breast cancer pretreated with anti-HER2 therapy
2012
Validation of the Spanish Version of the Food Allergy Quality of Life Questionnaire- Parent Form (S-FAQLQ-PF)
2017
Risk factors for second primary tumours in breast cancer survivors
2008
Cáncer de riñón hereditario
2009
Use of Bevacizumab as a First-Line Treatment for Metastatic Breast Cancer
2015
[The nasojejunal tube in early postoperative nutrition].
1999
Abstract P6-08-10: Prospective study of the impact of the Prosigna™ assay on adjuvant clinical decision-making in women with estrogen receptor-positive, HER2-negative, node-negative breast cancer: A GEICAM study
2015
Safety and Efficacy of Neratinib (HKI-272) in Combination with Vinorelbine in ErbB2+ Metastatic Breast Cancer.
2009
SOLTI NeoPARP: A phase II, randomized study of two schedules of iniparib plus paclitaxel and paclitaxel alone as neoadjuvant therapy in patients with triple-negative breast cancer (TNBC).
2012
DNA-Repair Gene Polymorphisms Predict Favorable Clinical Outcome Among Patients With Advanced Squamous Cell Carcinoma of the Head and Neck Treated With Cisplatin-Based Induction Chemotherapy
2006